Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Peoples Bancorp Inc. PEBO stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:
A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.
On this front, Peoples Bancorp has a trailing twelve months PE ratio of 17, as you can see in the chart below:
This level actually compares pretty favorably with the market at large, as the PE ratio for the S&P 500 stands at about 21.3. If we focus on the long-term PE trend, Peoples Bancorp’s current PE level puts it above its midpoint over the past five years, with the number having risen rapidly over the past few months.
Further, the stock’s PE also compares favorably with the broader industry’s trailing twelve months PE ratio, which stands at 17.5. At the very least, this indicates that the stock is relatively undervalued right now, compared to its peers.
We should also point out that Peoples Bancorp has a forward PE ratio (price relative to this year’s earnings) of just 15.7, so it is fair to say that a slightly more value-oriented path may be ahead for Peoples Bancorp stock in the near term too .
Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.
Right now, Peoples Bancorp has a P/S ratio of about 3.4. This is a bit lower than the S&P 500 average, which comes in at 3.3x right now. Also, as we can see in the chart below, this is well below the highs for this stock in particular over the past few years.
Broad Value Outlook
In aggregate, Peoples Bancorp currently has a Value Score of B, putting it into the top 40% of all stocks we cover from this look. This makes Peoples Bancorp a solid choice for value investors.
What About the Stock Overall?
Though Peoples Bancorp might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth Score of D and a Momentum Score of C. This gives PEBO a Zacks VGM score — or its overarching fundamental grade — of C. (You can read more about the Zacks Style Scores here >>)
Meanwhile, the company’s recent earnings estimates have been mixed at best. The current quarter has seen two estimates go lower in the past sixty days, while the full year estimate has seen three up in the same time period.
This has had just a small impact on the consensus estimate though as the current quarter consensus estimate has decreased 5.8% in the past two months, while the full year estimate has increased 3.5%. You can see the consensus estimate trend and recent price action for the stock in the chart below:
Peoples Bancorp Inc. Price and Consensus
Peoples Bancorp Inc. Price and Consensus | Peoples Bancorp Inc. Quote
This somewhat mixed trend is why the stock has just a Zacks Rank #3 (Hold) and why we are looking for in-line performance from the company in the near term.
Peoples Bancorp is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. However, with a sluggish industry rank (among Bottom 34% of more than 250 industries) and a Zacks Rank #3, it is hard to get too excited about this company overall.
However, over the past two years, the broader industry has clearly outperformed the market at large, as you can see below:
Despite the bright broader-industry performance, value investors might want to wait for estimates and analyst sentiment to turn around in this name first, but once that happens, this stock could be a compelling pick.
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Peoples Bancorp Inc. (PEBO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research